Download
s00103-020-03231-7.pdf 812,02KB
WeightNameValue
1000 Titel
  • Rekombinante Allergene, Peptide und Virus-like Particles in der Immuntherapie von Allergien
1000 Titelzusatz
  • Recombinant allergens, peptides, and virus-like particles for allergy immunotherapy
1000 Autor/in
  1. Holzhauser, Thomas |
  2. Schuler, Frank |
  3. Dudek, Simone |
  4. Kaul, Susanne |
  5. Vieths, Stefan |
  6. Mahler, Vera |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-23
1000 Erschienen in
1000 Quellenangabe
  • 63(11):1412-1423
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00103-020-03231-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648003/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Currently, extract-based therapeutic allergens from natural allergen sources (e.g., house dust mites, tree and grass pollen) are used for allergen-specific immunotherapy (AIT), the only causative therapy that can exhibit positive disease-modifying effects by tolerance induction and prevention of disease progression. Due to variations in the natural composition of the starting materials and different manufacturing processes, there are variations in protein content, allergen composition, and allergenic activity of similar products, which poses specific challenges for their standardization. The identification of the nucleotide sequences of allergenic proteins led to the development of molecular AIT approaches. This allows for the application of exclusively relevant structures as chemically synthesized peptides, recombinant single allergens, or molecules with hypoallergenic properties that potentially allow for an up-dosing with higher allergen-doses without allergic side effects leading more quickly to effective cumulative doses. Further modifications of AIT preparations to improve allergenic and immunogenic properties may be achieved, e.g., by including the use of virus-like particles (VLPs). To date, the herein described therapeutic approaches have been tested in clinical trials only. This article provides an overview of published molecular approaches for allergy treatment used in clinical AIT studies. Their added value and challenges compared to established therapeutic allergens are discussed. The aim of these approaches is to develop highly effective and well-tolerated AIT preparations with improved patient acceptance and adherence.
1000 Sacherschließung
lokal Desensitization, Immunologic [MeSH]
lokal Hypersensitivity/therapy [MeSH]
lokal Leitthema
lokal Humans [MeSH]
lokal Rekombinante Allergene
lokal Immunotherapy [MeSH]
lokal Peptide
lokal VLP
lokal Recombinant allergens
lokal Peptides
lokal Regulation
lokal Germany [MeSH]
lokal Allergens [MeSH]
lokal Peptides [MeSH]
lokal AIT
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SG9semhhdXNlciwgVGhvbWFz|https://frl.publisso.de/adhoc/uri/U2NodWxlciwgRnJhbms=|https://frl.publisso.de/adhoc/uri/RHVkZWssIFNpbW9uZQ==|https://frl.publisso.de/adhoc/uri/S2F1bCwgU3VzYW5uZQ==|https://frl.publisso.de/adhoc/uri/VmlldGhzLCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/TWFobGVyLCBWZXJh
1000 Hinweis
  • DeepGreen-ID: 31472f67aeed4b7d989e6c608a09188d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6441665.rdf
1000 Erstellt am 2023-04-25T18:01:58.365+0200
1000 Erstellt von 322
1000 beschreibt frl:6441665
1000 Zuletzt bearbeitet 2023-10-19T10:41:25.504+0200
1000 Objekt bearb. Thu Oct 19 10:41:25 CEST 2023
1000 Vgl. frl:6441665
1000 Oai Id
  1. oai:frl.publisso.de:frl:6441665 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source